Precision BioSciences, Inc.
DTIL • NASDAQ
Precision BioSciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Amoroso, with a market cap of $148.9M.
CEOMichael Amoroso
Next Earnings
Upcoming earnings announcement for Precision BioSciences, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.59
Revenue Estimate
$5.5M
Earnings History
Past 12 earnings reports for Precision BioSciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | $1.05Est: -$0.47 | +323.4% | $34.2MEst: $10.4M | +230.0% |  10-K |
| Nov 3, 2025 | Q3 2025 | -$1.84Est: -$1.45 | -26.9% | $13.0KEst: $7.7M | -99.8% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$2.13Est: -$1.36 | -56.6% | $18.0KEst: $9.2M | -99.8% | 10-Q |
| May 15, 2025 | Q1 2025 | -$2.21Est: -$2.42 | +8.7% | $29.0KEst: $5.0M | -99.4% | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$2.22Est: -$2.94 | +24.5% | $638.0K | — | 10-K |
| Nov 4, 2024 | Q3 2024 | -$2.25Est: -$1.92 | -17.2% | $576.0KEst: $6.4M | -90.9% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $4.67Est: -$1.50 | +411.3% | $49.9MEst: $8.9M | +463.2% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.35Est: -$1.91 | +81.7% | $17.6MEst: $6.0M | +192.1% | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$3.35Est: -$2.05 | -63.4% | $7.0MEst: $12.5M | -43.6% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$2.10Est: -$5.10 | +58.8% | $13.1MEst: $8.6M | +52.6% | — |
| Aug 4, 2023 | Q2 2023 | -$3.00Est: -$6.90 | +56.5% | $19.8MEst: $6.6M | +200.7% | 10-Q |
| May 9, 2023 | Q1 2023 | -$6.90Est: -$6.90 | 0.0% | $8.8MEst: $5.7M | +54.9% | — |